Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: PXL Platinum 330 system + Riboflavin 0.25% TE Solution; Other: Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution; Other: Standard of Care Therapy + Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: PXL Platinum 330 system + Riboflavin 0.25% TE Solution; Other: Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution; Other: Standard of Care Therapy + Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: PXL Platinum 330 system + Riboflavin 0.25% TE Solution; Other: Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution; Other: Standard of Care Therapy + Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: PXL Platinum 330 system + Riboflavin 0.25% TE Solution; Other: Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Condition: Keratitis Interventions: Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution; Other: Standard of Care Therapy + Sham CXL + Artificial Tears Sponsor: Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials
Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS
Conditions: Keratoconus; Corneal Cross-linking Interventions: Other: accelerated custom-fast CXL; Other: Standard CXL Sponsor: Ciro Caruso Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2021 Category: Research Source Type: clinical trials
Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS
Condition: Keratoconus Interventions: Other: accelerated custom-fast CXL; Other: Standard CXL Sponsor: Ciro Caruso Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2021 Category: Research Source Type: clinical trials